Emerging Markets

Marking another step in Dr Reddy’s diverse corporate strategy, the company has signed a memorandum of understanding with Kainomyx for the development and commercialization of anti-malarials in multiple markets.

In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry. 

The vaccines alliance says its First Response Fund could be used to cover the cost of doses and has outlined plans for a vaccine stockpile. Some experts have criticized the slow rate of response to mpox and called for more solidarity on vaccine provision at global level.

Consumer health companies need to meet consumers where they are in their life-stage journeys, providing healthy aging solutions like dietary supplements that have clearly communicated and science-backed benefits, argued panelists at a recent IQVIA Consumer Health webinar. This is particularly the case for women, who are underserved and want natural support for changes like the menopause, said Haleon's Sheryl Tan. 

UK prebiotic specialist Clasado Biociences is expanding across APAC and Eastern Europe through two recently-signed distribution deals: Alliance Nutrition Group’s Shanghai Prochin for China and BART in Poland.

China's deepening economic downturn is impacting foreign business confidence in China, while recent high-profile events have created uncertainties around the go-global push by Chinese pharma firms, at a time when this has become critical to their very survival.

A deal between Stada Arzneimittel and Adcan Pharma will see the former exclusively market and commercialize in the UAE a portfolio of 15 consumer healthcare products produced and supplied by the latter.

Poland is slowly expanding beyond its position as a central European generics hub. More established companies are adding innovative medicine pipelines and a small number of biotechs are making international deals.  

At this week’s World Health Assembly, a working group will be set up to discuss the next steps for talks on a global pandemic treaty and try to reach a final agreement on amendments to the International Health Regulations.

Bayer Consumer Health's recently established Precision Health unit launches its Aspirin Heart Risk Assessment tool in Saudi Arabia. Developed in partnership with British medtech firm Huma Therapeutics, Bayer is planning to roll out the digital tool to other countries in the Middle East and also Latin America. 

On the heels of a decade-long partnership with ViiV Healthcare that has helped 24 million people with HIV, the Medicines Patent Pool introduces a new version of its patent database for essential medicines and COVID-19 vaccines.

US-China tensions, the increasing importance of Singapore as a doorway to the Asia-Pacific region, growing AI innovation in South Korea and a changing clinical trials landscape in Japan are just some of the recent developments in APAC. 

Discussions during the second day of the 25th session of the International Medical Device Regulators Forum focused on the establishment of working groups to iron out a plethora of issues for international harmonization.

COVAX, a global initiative that was established to provide equitable access to COVID-19 vaccines worldwide, will end on 31 December, freeing up funds for new inoculation equity schemes across the globe.

Stada has struck a deal with CR Sanjiu for distribution and promotion of its cough and cold brands after identifying expansion in the Chinese market as a key strategic target.

Stada has struck a deal with CR Sanjiu for distribution and promotion of its cough and cold brands after identifying expansion in the Chinese market as a key strategic target.

“We believe that access to quality healthcare is a fundamental human right, and by joining the global effort to achieve Universal Health Coverage, we aim to create a more equitable and healthier world for everyone,” says Global Self-Care Federation director general, Judy Stenmark, endorsing the Self-Care for Universal Health Coverage Declaration alongside LATAM policy makers and regulators at the 1st Latin American Self-Care Regional Congress in Sao Paulo, Brazil.

A lot of work needs to be done, and many compromises struck, if talks on the proposed pandemic accord are to be completed in time for the May 2024 deadline.

A lack of accessible diagnostics in Africa threatens to both limit the roll-out of life saving drugs and the development of new ones.

The Brazilian medicines regulator has published a guide for companies conducting real-world evidence studies. Already in force, it is open to comments until 2024 and updates may be made.